Novo Nordisk Expands Its AI Push With AWS, But Can It Accelerate Drug Discovery?

Summary

Novo Nordisk has expanded its artificial intelligence initiatives through a partnership with Amazon Web Services to accelerate drug discovery efforts. The article questions whether the collaboration will effectively translate AI capabilities into faster drug development.